Non-heme dioxygenases: Cellular sensors and regulators jelly rolled into one?

Nature Chemical Biology

Volumn 3, Issue 3, 2007, Pages 144-153

  Ozer, Abdullah ^a   Bruick, Richard K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; AMINO ACID; DIOXYGENASE; FERROUS ION; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; OXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE;

BIOSENSOR; CELL FUNCTION; CELL METABOLISM; ENZYME MECHANISM; HUMAN; HYDROXYLATION; HYPOXIA; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW;

EID: 33847050240     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio863     Document Type: Review

References (119)

1. Clifton, I.J. et al. Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins. J. Inorg. Biochem. 100, 644-669 (2006).
2. Koehntop, K.D., Emerson, J.P. & Que, L., Jr. The 2-His-1-carboxylate facial triad: a versatile platform for dioxygen activation by mononuclear non-heme iron(II) enzymes. J. Biol. Inorg. Chem. 10, 87-93 (2005).
3. Zhou, J., Gunsior, M., Bachmann, B.O., Townsend, C.A. & Solomon, E.I. Substrate binding to the α-ketoglutarate-dependent non-heme iron enzyme clavaminate synthase 2: coupling mechanism of oxidative decarboxylation and hydroxylation. J. Am. Chem. Soc. 120, 13539-13540 (1998).
4. Bernhardt, R. Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 124, 128-145 (2006).
5. Wu, M., Moon, H.S., Begley, T.P., Myllyharju, J. & Kivirikko, K.I. Mechanism-based inactivation of the human prolyl-4-hydroxylase by 5-oxaproline-containing peptides: evidence for a prolyl radical intermediate. J. Am. Chem. Soc. 121, 587-588 (1999).
6. Burzlaff, N.I. et al. The reaction cycle of isopenicillin N synthase observed by X-ray diffraction. Nature 401, 721-724 (1999).
7. Bugg, T.D.H. Dioxygenase enzymes: catalytic mechanisms and chemical models. Tetrahedron 59, 7075-7101 (2003).
8. Hausinger, R.P. FeII/α-ketoglutarate-dependent hydroxylases and related enzymes. Crit. Rev. Biochem. Mol. Biol. 39, 21-68 (2004).
9. Price, J.C., Barr, E.W., Tirupati, B., Bollinger, J.M. & Krebs, C. The first direct characterization of a high-valent iron intermediate in the reaction of an α-ketoglutarate- dependent dioxygenase: a high-spin Fe(IV) complex in taurine/α-ketoglutarate dioxygenase (TauD) from Escherichia coli. Biochemistry 42, 7497-7508 (2003).
10. Hoffart, L.M., Barr, E.W., Guyer, R.B., Bollinger, J.M. & Krebs, C. Direct spectroscopic detection of a C-H-cleaving high-spin Fe(IV) complex in a prolyl-4-hydroxylase. Proc. Natl. Acad. Sci. USA 103, 14738-14743 (2006).
11. Myllyharju, J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol. 22, 15-24 (2003).
12. Bhattacharjee, A. & Bansal, M. Collagen structure: the Madras triple helix and the current scenario. IUBMB Life 57, 161-172 (2005).
13. Kivirikko, K.I. & Prockop, D.J. Enzymatic hydroxylation of proline and lysine in protocollagen. Proc. Natl. Acad. Sci. USA 57, 782-789 (1967).
14. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J. & Whitelaw, M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861 (2002).
15. Stenflo, J. et al. Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase. Proc. Natl. Acad. Sci. USA 86, 444-447 (1989).
16. Liu, A. et al. Alternative reactivity of an α-ketoglutarate- dependent iron(II) oxygenase: enzyme self-hydroxylation. J. Am. Chem. Soc. 123, 5126-5127 (2001).
17. Semenza, G.L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983-1991 (2000).
18. Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732 (2003).
19. Wang, G.L., Jiang, B.H. & Semenza, G.L. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216, 669-675 (1995).
20. Yang, J. et al. Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor. J. Biol. Chem. 280, 36047-36054 (2005).
21. Huang, L.E., Arany, Z., Livingston, D.M. & Bunn, H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J. Biol. Chem. 271, 32253-32259 (1996).
22. Salceda, S. & Caro, J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647 (1997).
23. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992 (1998).
24. Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y. & Poellinger, L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525 (1999).
25. Jiang, B.H., Zheng, J.Z., Leung, S.W., Roe, R. & Semenza, G.L. Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272, 19253-19260 (1997).
26. Pugh, C.W., O'Rourke, J.F., Nagao, M., Gleadle, J.M. & Ratcliffe, P.J. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit. J. Biol. Chem. 272, 11205-11214 (1997).
27. 2 sensing. Science 292, 464-468 (2001).
28. 2-regulated prolyl hydroxylation. Science 292, 468-472 (2001).
29. Yu, F., White, S.B., Zhao, Q. & Lee, F.S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635 (2001).
30. Hon, W.C. et al. Structural basis for the recognition of hydroxyproline in HIF-1 α by pVHL. Nature 417, 975-978 (2002).
31. Min, J.H. et al. Structure of an HIF-1α -pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889 (2002).
32. Bruick, R.K. & McKnight, S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340 (2001).
33. Epstein, A.C. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54 (2001).
34. Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99, 13459-13464 (2002).
35. Hewitson, K.S. et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355 (2002).
36. Lando, D. et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471 (2002).
37. Dann, C.E., III, Bruick, R.K. & Deisenhofer, J. Structure of factor-inhibiting hypoxiainducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway. Proc. Natl. Acad. Sci. USA 99, 15351-15356 (2002).
38. Elkins, J.M. et al. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 α. J. Biol. Chem. 278, 1802-1806 (2003).
39. Lee, C., Kim, S.J., Jeong, D.G., Lee, S.M. & Ryu, S.E. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. J. Biol. Chem. 278, 7558-7563 (2003).
40. McDonough, M.A. et al. Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc. Natl. Acad. Sci. USA 103, 9814-9819 (2006).
41. Huang, J., Zhao, Q., Mooney, S.M. & Lee, F.S. Sequence determinants in hypoxiainducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J. Biol. Chem. 277, 39792-39800 (2002).
42. Hirsila, M., Koivunen, P., Gunzler, V., Kivirikko, K.I. & Myllyharju, J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278, 30772-30780 (2003).
43. Koivunen, P., Hirsila, M., Kivirikko, K.I. & Myllyharju, J. The length of peptide substrates has a marked effect on hydroxylation by the HIF prolyl 4-hydroxylases. J. Biol. Chem. 281, 28712-28720 (2006).
44. Sanchez-Puig, N., Veprintsev, D.B. & Fersht, A.R. Binding of natively unfolded HIF-1α ODD domain to p53. Mol. Cell 17, 11-21 (2005).
45. Chan, D.A., Sutphin, P.D., Yen, S.E. & Giaccia, A.J. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 α. Mol. Cell. Biol. 25, 6415-6426 (2005).
46. 2 tension. Am. J. Physiol. 271, C1172-C1180 (1996).
47. Koivunen, P., Hirsila, M., Gunzler, V., Kivirikko, K.I. & Myllyharju, J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 279, 9899-9904 (2004).
48. Mahon, P.C., Hirota, K. & Semenza, G.L. FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686 (2001).
49. Linke, S. et al. Substrate requirements of the oxygen-sensing asparaginyl hydroxylase factor-inhibiting hypoxia-inducible factor. J. Biol. Chem. 279, 14391-14397 (2004).
50. Dames, S.A., Martinez-Yamout, M., De Guzman, R.N., Dyson, H.J. & Wright, P.E. Structural basis for Hif-1 α/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. USA 99, 5271-5276 (2002).
51. Freedman, S.J. et al. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 α. Proc. Natl. Acad. Sci. USA 99, 5367-5372 (2002).
52. Myllyharju, J. & Kivirikko, K.I. Characterization of the iron- and 2-oxoglutarate-binding sites of human prolyl 4-hydroxylase. EMBO J. 16, 1173-1180 (1997).
53. Stolze, I.P. et al. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (HIF) in regulating HIF transcriptional target genes. J. Biol. Chem. 279, 42719-42725 (2004).
54. 2 sensing. J. Biol. Chem. 275, 25130-25138 (2000).
55. Hagen, T., Taylor, C.T., Lam, F. & Moncada, S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science 302, 1975-1978 (2003).
56. Doege, K., Heine, S., Jensen, I., Jelkmann, W. & Metzen, E. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106, 2311-2317 (2005).
57. Brunelle, J.K. et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1, 409-414 (2005).
58. Guzy, R.D. et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401-408 (2005).
59. Mansfield, K.D. et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell Metab. 1, 393-399 (2005).
60. Gerald, D. et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118, 781-794 (2004).
61. Knowles, H.J., Raval, R.R., Harris, A.L. & Ratcliffe, P.J. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63, 1764-1768 (2003).
62. Salnikow, K. et al. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 279, 40337-40344 (2004).
63. Lawson, J.W.R., Guynn, R.W., Cornell, N. & Veech, R.L. in Gluconeogenesis: Its Regulation in Mammalian Species (eds. Hanson, R.W. & Mehlman, M.A.) 165-220 (John Wiley and Sons, New York, 1976).
64. Metzen, E. et al. Intracellular localisation of human HIF-1 α hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326 (2003).
65. Soilleux, E.J. et al. Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues. Histopathology 47, 602-610 (2005).
66. Dalgard, C.L., Lu, H., Mohyeldin, A. & Verma, A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem. J. 380, 419-424 (2004).
67. Lu, H. et al. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280, 41928-41939 (2005).
68. Selak, M.A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77-85 (2005).
69. Pollard, P.J. et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231-2239 (2005).
70. Isaacs, J.S. et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143-153 (2005).
71. Strahl, B.D. & Allis, C.D. The language of covalent histone modifications. Nature 403, 41-45 (2000).
72. Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349-352 (1997).
73. Bannister, A.J. & Kouzarides, T. Reversing histone methylation. Nature 436, 1103-1106 (2005).
74. Bannister, A.J., Schneider, R. & Kouzarides, T. Histone methylation: dynamic or static? Cell 109, 801-806 (2002).
75. Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 (2004).
76. Metzger, E. et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437, 436-439 (2005).
77. Forneris, F., Binda, C., Vanoni, M.A., Mattevi, A. & Battaglioli, E. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett. 579, 2203-2207 (2005).
78. Falnes, P.O., Johansen, R.F. & Seeberg, E. AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419, 178-182 (2002).
79. Trewick, S.C., McLaughlin, P.J. & Allshire, R.C. Methylation: lost in hydroxylation? EMBO Rep. 6, 315-320 (2005).
80. Fodor, B.D. et al. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 20, 1557-1562 (2006).
81. Klose, R.J., Kallin, E.M. & Zhang, Y. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7, 715-727 (2006).
82. Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811-816 (2006).
83. Whetstine, J.R. et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467-481 (2006).
84. Yamane, K. et al. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125, 483-495 (2006).
85. Cloos, P.A. et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442, 307-311 (2006).
86. Chen, Z. et al. Structural insights into histone demethylation by JMJD2 family members. Cell 125, 691-702 (2006).
87. Zhang, D., Yoon, H.G. & Wong, J. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol. Cell. Biol. 25, 6404-6414 (2005).
88. Ozer, A., Wu, L.C. & Bruick, R.K. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl. Acad. Sci. USA 102, 7481-7486 (2005).
89. Baek, J.H. et al. OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α. Mol. Cell 17, 503-512 (2005).
90. Masson, N. et al. The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. FEBS Lett. 570, 166-170 (2004).
91. Choi, K.O. et al. Inhibition of the catalytic activity of hypoxia-inducible factor-1α- prolyl-hydroxylase 2 by a MYND-type zinc finger. Mol. Pharmacol. 68, 1803-1809 (2005).
92. Nakayama, K. et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952 (2004).
93. Appelhoff, R.J. et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458- 38465 (2004).
94. Stiehl, D.P. et al. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281, 23482-23491 (2006).
95. Khanna, S., Roy, S., Maurer, M., Ratan, R.R. & Sen, C.K. Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point. Free Radic. Biol. Med. 40, 2147-2154 (2006).
96. Morita, M. et al. HLF/HIF-2α is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 22, 1134-1146 (2003).
97. Siddiq, A. et al. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J. Biol. Chem. 280, 41732-41743 (2005).
98. Temes, E. et al. Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase. J. Biol. Chem. 280, 24238-24244 (2005).
99. Yeo, E.J. et al. Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1. Blood 107, 916-923 (2006).
100. Takeda, K. et al. Placental but not heart defects are associated with elevated hypoxiainducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 26, 8336-8346 (2006).
101. Percy, M.J. et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. USA 103, 654-659 (2006).
102. Kuznetsova, A.V. et al. von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc. Natl. Acad. Sci. USA 100, 2706-2711 (2003).
103. Cummins, E.P. et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc. Natl. Acad. Sci. USA 103, 18154-18159 (2006).
104. Cockman, M.E. et al. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl. Acad. Sci. USA 103, 14767-14772 (2006).
105. Chuikov, S. et al. Regulation of p53 activity through lysine methylation. Nature 432, 353-360 (2004).
106. Kouskouti, A., Scheer, E., Staub, A., Tora, L. & Talianidis, I. Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol. Cell 14, 175-182 (2004).
107. Polevoda, B., Martzen, M.R., Das, B., Phizicky, E.M. & Sherman, F. Cytochrome c methyltransferase, Ctm1p, of yeast. J. Biol. Chem. 275, 20508-20513 (2000).
108. Inamitsu, M., Itoh, S., Hellman, U., Ten Dijke, P. & Kato, M. Methylation of Smad6 by protein arginine N-methyltransferase 1. FEBS Lett. 580, 6603-6611 (2006).
109. El-Andaloussi, N. et al. Methylation of DNA polymerase β by protein arginine methyltransferase 1 regulates its binding to proliferating cell nuclear antigen. FASEB J. 21, 26-34 (2007).
110. Cuthbert, G.L. et al. Histone deimination antagonizes arginine methylation. Cell 118, 545-553 (2004).
111. van der Wel, H., Ercan, A. & West, C.M. The Skp1 prolyl hydroxylase from Dictyostelium is related to the hypoxia-inducible factor-α class of animal prolyl 4-hydroxylases. J. Biol. Chem. 280, 14645-14655 (2005).
112. Elvidge, G.P. et al. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1α, HIF-2α, and other pathways. J. Biol. Chem. 281, 15215-15226 (2006).
113. Kruszewski, M. The role of labile iron pool in cardiovascular diseases. Acta Biochim. Pol. 51, 471-480 (2004).
114. Hanson, E.S., Rawlins, M.L. & Leibold, E.A. Oxygen and iron regulation of iron regulatory protein 2. J. Biol. Chem. 278, 40337-40342 (2003).
115. Wang, J. et al. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol. Cell. Biol. 24, 954-965 (2004).
116. Rouault, T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2, 406-414 (2006).
117. Myllyla, R., Tuderman, L. & Kivirikko, K.I. Mechanism of prolyl hydroxylase reaction. 2. Kinetic-analysis of reaction sequence. Eur. J. Biochem. 80, 349-357 (1977).
118. Hirsila, M. et al. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J. 19, 1308-1310 (2005).
119. McNeill, L.A. et al. Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol. Biosyst. 1, 321-324 (2005).